Pubblicazioni Scientifiche


2011

  1. Cappello F., Caramori G, Campanella C, Vicari C, Gnemmi I, Zanini A, Spanevello A, Capelli A, La Rocca G, Anzalone R, Bucchieri F, D’Anna SE, Ricciardolo FLM, Brun P, Balbi B, Carone M, Zummo G, Conway de Macario E, Macario AJL, Di Stefano A. Convergent Sets of Data from In Vivo and In Vitro Methods Point to an Active Role of Hsp60 in Chronic Obstructive Pulmonary Disease Pathogenesis. PLoS ONE. 2011; 6:e28200.
  2. La Rocca G. Editorial – Connecting the Dots: The Promises of Wharton’s Jelly Mesenchymal Stem Cells for Tissue Repair and Regeneration. The Open Tissue Engineering and Regenerative Medicine Journal. 2011; 4: 3-5.
  3. Lo Iacono M, Anzalone R, Corrao S, Giuffrè M, Di Stefano A, Giannuzzi P, Cappello P, Farina F, La Rocca G: Perinatal and Wharton’s Jelly-Derived Mesenchymal Stem Cells in Cartilage Regenerative Medicine and Tissue Engineering Strategies. The Open Tissue Engineering and Regenerative Medicine Journal. 2011; 4: 72-81.
  4. Macario, A.J.L. Sobre chaperonas, epigénesis y enfermedad (2011) Medicina, 71 (6), pp. 589-590.
  5. Haidara M, Mikhailidis DP, Yassin HZ, Dobutovic B, Smiljanic KT, Soskic S, Mousa SA, Rizzo M, Isenovic ER. Evaluation of the possible contribution of antioxidants administration in metabolic syndrome. CurrPharmDes. 2011; 17:3699-3712.
  6. Novo G, Cappello F, Rizzo M, Fazio G, Zambuto S, Tortorici E, Gammazza AM, Corrao S, Zummo G, Conway De Macario E, Macario AJL, Assennato P, Novo S, Volti GL. Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction. Transl Res. 2011; 157:285-292.
  7. Pierucci M, Galati S, Valentino M, Di Matteo V, Benigno A, Muscat R, Pitruzzella A, Di Giovanni G. Nitric Oxide Modulation of The Basal Ganglia Circuitry: Therapeutic Implication for Parkinson’s Disease and Other Motor Disorders. CNS Neurol Disord Drug Targets.2011; 10(7):777-91.
  8. Rizzo M, Macario AJL, Conway de Macario E, Gouni-Berthold I, Berthold HK, Rini GB, Zummo G, Cappello F. Heat Shock Protein-60 and Risk for Cardiovascular Disease. Curr Pharm Des. 2011; 17:3662-3668.
  9. Rizzo M, Mikhailidis DP. There is more to predicting vascular disease than just established risk factors. CurrPharmDes. 2011; 17:3608-3610.
  10. Sala A, Toto M, Pinello L, Gabriele A, Di Benedetto V, Ingrassia AM, Lo Bosco G, Di Gesù V, Giancarlo R, Corona DF. Genome-wide characterization of chromatin binding and nucleosome spacing activity of the nucleosome remodelling ATPase ISWI. EMBO J. 2011; 30:1766-1777.
  11. Terenzi A, Barone G, Palumbo Piccionello A, Giorgi G, Guarcello A, Pace A. Synthesis and chemical characterization of CuII, NiII and ZnII complexes of 3,5-bis(20-pyridyl)-1,2,4-oxadiazole and 3-(20-pyridyl)5-(phenyl)-1,2,4-oxadiazole Ligands. InorgChim Acta. 2011, 373:62-67.
  12. Tiberini A, Davino S, Davino M, Tomassoli L. Complete sequence, genotyping and comparative analysis of Pepino mosaic virus isolates from Italy. J Plant Pathol. 2011,93:437-442.
  13. Tomasello G, Sciumè C, Rappa C, Rodolico V, Zerilli M, Martorana A, Cicero G, De Luca R, Damiani P, Accardo FM, Romeo M, Bonaventura G, Modica G, Zummo G, Conway de Macario E, Macario AJL, Cappello F. Hsp10, Hsp70, and Hsp90 immunohistochemical levels change in ulcerative colitis after therapy. Eur J Histochem. 2011; 55:e38.
  14. Tomasello G, Rodolico V, Zerilli M, Martorana A, Bucchieri F, Pitruzzella A, Gammazza AM, David S, Rappa F, Zummo G, Damiani P, Accomando S, Rizzo M, de Macario E, Macario AJL, Cappello F. Changes in Immunohistochemical Levels and Subcellular Localization After Therapy and Correlation and Colocalization With CD68 Suggest a Pathogenetic Role of Hsp60 in Ulcerative Colitis. Appl Immunohistochem Mol Morphol. 2011; 19:552-561.
  15. Tselepis AF, Rizzo M, Goudevenos IA. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2). CurrPharmDes. 2011; 17:3656-3661.